Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-004293-10Phase 4Terminated
Phase 4, open-label, single-arm trial of botulinum toxin type A in hyperhidrosis and Stump hyperhidrosis, sponsored by Hospital Universitari Joan XXIII de Tarragona. Primary endpoint: Hyperhidrosis symptom improvement. Started Apr 2014; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-004293-10.